CDKN2A and neoplasm: Furthermore, p16 and p21, which are downstream effectors of p53 and traditionally recognized as tumor suppressors, have also been implicated in tumor-promoting activities under specific conditions, particularly through enhancing the chemotactic activity of monocytic myeloid-derived suppressor cells (Mo-MDSCs).